Volume 21 Number 24

This year-end issue of EuroIntervention begins with a State-of-the-Art on transcatheter edge-to-edge repair in mitral regurgitation; and offers original research on the Watchman FLX vs Watchman 2.5; the predictors of underexpansion with the ACURATE neo platform; and valve-in-root TAVI after an aortic root operation; we also share three research correspondences on determining coronary microvascular dysfunction endotypes using invasive exercise testing; the 5-year results of SORT OUT X; and an analysis of RADIANCE-HTN TRIO on antihypertensive drugs; and more...

Snapshot

State-of-the-Art on TEER in MR; Watchman FLX vs 2.5; predictors of underexpansion with ACURATE neo; valve-in-root TAVI; CMD endotypes using invasive exercise testing; SORT OUT X: 5-year results; antihypertensive drugs in RADIANCE-HTN TRIO

State of the art

Transcatheter edge-to-edge repair in secondary mitral regurgitation

Rodés-Cabau J, Mengi S, Salaun E, Paradis J, Abraham W

10.4244/EIJ-D-25-00116

Original Research

Watchman FLX versus Watchman 2.5 for left atrial appendage closure: a propensity score-matched analysis

Galea R, La Fazia V, Della Rocca D, Gasys A, Bini T, Siontis G, Gianni C, Roten L, Mohanty S, Brugger N, Torlapati P, Horton R, Al-Ahmad A, Biase L, Natale A, Räber L

10.4244/EIJ-D-25-00757

Predictors of underexpansion after transcatheter aortic valve implantation with the ACURATE neo valve

Alvarez-Covarrubias H, Taniguchi Y, Jurisic M, Altaner N, Syryca F, Blum E, Pellegrini C, Duesmann C, Mayr N, Rheude T, Schunkert H, Kastrati A, Cassese S, Xhepa E, Joner M

10.4244/EIJ-D-25-00489

Feasibility of valve-in-root transcatheter aortic valve implantation in patients with prior aortic root replacement and repair

Zientara A, Brizzi F, von zur Mühlen C, Bruijnen H, Kreibich M, Berger T, Kondov S, Siepe M, Rylski B, Benk J, Beyersdorf F, Rilinger J, Maier A, Oettinger V, Westermann D, Czerny M, Gottardi R

10.4244/EIJ-D-24-01168

Research Correspondence

Phenotyping coronary microvascular dysfunction endotypes using invasive exercise stress testing

Rahoual G, Procopi N, Beaupré F, Michon M, Martinez C, Guedeney P, Hammoudi N, Hatem S, Vicaut E, Kerneis M, Silvain J, Montalescot G, Zeitouni M, of the ACTION Study Group o

10.4244/EIJ-D-25-00319

Dual-therapy CD34 antibody-covered sirolimus-eluting COMBO stents versus sirolimus-eluting Orsiro stents in percutaneous coronary intervention: five-year outcomes of the SORT OUT X randomised clinical trial

Jakobsen L, Christiansen E, Frøslev T, Raungaard B, Lassen J, Eftekhari A, Jensen L

10.4244/EIJ-D-25-00667

Efficacy of ultrasound renal denervation adjusted for changes in detected antihypertensive medications in the RADIANCE-HTN TRIO Study

Zeijen V, Azizi M, Kirtane A, McClure C, Kably B, Daemen J

10.4244/EIJ-D-25-00482

Letter to the editor

Letter: Balancing, timing, and efficiency in tricuspid TEER

Ktenopoulos N, Apostolos A, Toutouzas K

10.4244/EIJ-D-25-00868

Reply: Balancing, timing, and efficiency in tricuspid TEER

Baldus S, Lurz P, of the TriCLASP study investigators o

10.4244/EIJ-D-25-00944